Imaging Thyroid Disease: Updates, Imaging Approach, and Management Pearls

https://doi.org/10.1016/j.rcl.2014.09.002Get rights and content

Section snippets

Key points

  • Thyroid cancer is the fastest increasing cancer in the United States. An exponential increase in incidence of thyroid cancer has been partly attributed to an increased work-up of incidentally detected thyroid nodules on imaging, especially ultrasonography and computed tomography (CT).

  • A categorization method has been proposed for guiding the evaluation of incidental thyroid nodules detected on CT, MR imaging, or PET/CT. The method is a 3-tiered system and is based on the patient’s age, nodule

Problem 1. The incidental thyroid nodule detected on computed tomography

A 51-year-old woman has an incidental 10-mm thyroid nodule on CT of the cervical spine performed for trauma. She has no personal or family history of thyroid disease. Should this nodule receive further work-up?

Problem 2. Goiter for preoperative planning

A 64-year-old man has a goiter causing dysphagia. Thyroid function tests are within the normal range. On physical examination the inferior border of the thyroid could not be appreciated, suggesting a substernal component. He undergoes CT for surgical planning. What is the best approach to the CT scan interpretation?

Problem 3. Hyperthyroidism

A 48-year-old woman presents with symptoms of hyperthyroidism and no palpable nodule. She has a suppressed thyroid-stimulating hormone (TSH) level and negative TSH-receptor antibodies. What is the next investigation and what are her treatment options?

Problem 4. Preoperative work-up of thyroid cancer

A 75-year-old woman has a 4-cm mass in the left lobe of thyroid with tracheal deviation and fixation. The biopsy was positive for papillary thyroid cancer. Given the signs concerning for tracheal invasion, she requires CT for surgical planning. Should contrast be administered? What is the best approach to the CT scan interpretation?

Problem 5. Surveillance and recurrent thyroid cancer

A 65-year-old woman with T2N0M0 disease was treated 2 years ago for papillary thyroid cancer with total thyroidectomy followed by RAI remnant thyroid ablation. She returns for follow-up and is asymptomatic from the perspective of her thyroid cancer, but her serum thyroglobulin level is high and increasing. What is the significance of high thyroglobulin level in an asymptomatic patient? How should she be imaged?

Summary

Diseases of the thyroid often require a multimodality, multidisciplinary, and collaborative approach across radiology, nuclear medicine, endocrinology, and endocrine surgery. Ultrasonography is ideal for characterizing thyroid nodules and guiding biopsy, but CT or MR imaging may be required preoperatively in cases of invasive thyroid cancer or substernal goiter. Imaging hyperthyroidism and recurrent thyroid cancer relies on nuclear medicine modalities. Excessive work-up of ITN and overdiagnosis

First page preview

First page preview
Click to open first page preview

References (55)

  • M. Bahl et al.

    Trends in incidentally identified thyroid cancers over a decade: a retrospective analysis of 2,090 surgical patients

    World J Surg

    (2014)
  • M. Bahl et al.

    Imaging-detected incidental thyroid nodules that undergo surgery: a single center’s experience over one year

    AJNR Am J Neuroradiol

    (2014)
  • R. Smith-Bindman et al.

    Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study

    JAMA Intern Med

    (2013)
  • Y. Ito et al.

    An observational trial for papillary thyroid microcarcinoma in Japanese patients

    World J Surg

    (2010)
  • J.K. Hoang et al.

    An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging

    AJNR Am J Neuroradiol

    (2014)
  • L. Davies et al.

    Current thyroid cancer trends in the United States

    JAMA Otolaryngol Head Neck Surg

    (2014)
  • J.K. Hoang et al.

    US Features of thyroid malignancy: pearls and pitfalls

    Radiographics

    (2007)
  • J.K. Hoang et al.

    High variability in radiologists' reporting practices for incidental thyroid nodules detected on CT and MRI

    AJNR Am J Neuroradiol

    (2014)
  • K.W. Kang et al.

    Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects

    J Clin Endocrinol Metab

    (2003)
  • T.Y. Kim et al.

    18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma

    Laryngoscope

    (2005)
  • J.Y. Choi et al.

    Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization

    J Nucl Med

    (2006)
  • P. Shie et al.

    Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography

    Nucl Med Commun

    (2009)
  • American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al.

    Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

    Thyroid

    (2009)
  • NCC guidelines thyroid carcinoma - nodule evaluation version 2. 2013. 2013. Available at:...
  • M.C. Frates et al.

    Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement

    Radiology

    (2005)
  • M. Bongiovanni et al.

    The Bethesda system for reporting thyroid cytopathology: a meta-analysis

    Acta Cytol

    (2012)
  • M. Rieu et al.

    Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre

    Clin Endocrinol (Oxf)

    (1993)
  • Cited by (27)

    • Imaging of the Thyroid: Practical Approach

      2021, Neuroimaging Clinics of North America
      Citation Excerpt :

      Malignant thyroid lesions are more likely to be hypoechoic solid, taller than wide, and lobulated on ultrasound examination and show calcifications (American College of Radiology [ACR]-TIRAD TR5, ATA high suspicion), from 26% to 79%, versus 8% to 39% in benign lesions, with microcalcifications more likely found in PTC (see Figs. 11 and 12).4,5,32 Nodal metastases are a common occurrence in PTC and can be seen in 40% of adults diagnosed with this malignancy.29 Metastatic lymph nodes may be cystic, necrotic, calcified or have internal hemorrhage and are well depicted on ultrasound examination.29

    • Improving Diagnostic Performance for Thyroid Nodules Classified as Bethesda Category III or IV: How and by Whom Ultrasonography Should be Performed

      2021, Journal of Surgical Research
      Citation Excerpt :

      The results of cross tabulation of US risk by provider, Bethesda cytology category and distribution of malignant versus benign nodules (Table 4) confirm that the ultrasound reports made by providers belonging to the dedicated team are much more reliable than the former. Moreover, in addition to the improved diagnostic performance of multidisciplinary team-based management of thyroid nodules from a surgical perspective,38 patient satisfaction, and cost savings should be taken into consideration due to the reduced number of visits.39 The present study investigated the relationship between the pretest probability of malignancy (relatively high in Bethesda III and higher in Bethesda IV cytology) and the performance of a prognostic test (ultrasound stratification).

    • Computed Tomography and MR Imaging of Thyroid Disease

      2020, Radiologic Clinics of North America
      Citation Excerpt :

      Many benign and malignant disorders can occur in the thyroid. Some thyroid diseases can be subclinical; however, others present with structural (ie, thyroid goiter) or functional (ie, thyroiditis) abnormalities.1,2 Thyroid cancer is the most common endocrine malignancy in the United States, affecting more than 400,000 people per year, with the incidence doubling between 2000 and 2009.

    View all citing articles on Scopus

    Funding: No grant support or funding was received for this project.

    Disclosure: The authors have nothing to disclose.

    View full text